financetom
Business
financetom
/
Business
/
'Sinners' and 'One Battle After Another' face off at drama-filled Oscars 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
'Sinners' and 'One Battle After Another' face off at drama-filled Oscars 
Mar 12, 2026 3:27 AM

* Academy Awards ceremony set for Sunday

* Many top categories hard to predict

* Conan O'Brien returns as host

By Lisa Richwine

LOS ANGELES, March 12 (Reuters) - Top names in Hollywood

will gather on Sunday to hand out the annual Academy Awards at a

red-carpet ceremony brimming with an unusual amount of drama in

the major races.

"One Battle After Another," starring Leonardo DiCaprio as a

one-time political radical now parenting a teenager, was seen as

the frontrunner for the coveted best picture prize after

stacking up trophy after trophy at recent ceremonies.

The vampire story "Sinners," a celebration of blues music and

Black culture in the Segregation-era U.S. South, made a late

surge with a win this month at the Actor Awards. The movie leads

all films with 16 nominations, a record number in the nearly

100-year history of the Oscars.

Jessie Buckley is seen as a sure thing for best actress. She is

nominated for playing Agnes Hathaway, the wife of William

Shakespeare, as the couple navigate the death of their

11-year-old son in "Hamnet." The remainder of the top categories

have no clear frontrunner, according to Hollywood awards

watchers.

Among the top awards, "five of the six seem to be up in the

air which is extremely rare," said Scott Feinberg, executive

editor of awards at The Hollywood Reporter.

Michael B. Jordan could take home best actor for his dual

role as twin brothers in "Sinners," Feinberg said. His

competition, however, includes previous winner DiCaprio, "Marty

Supreme" star Timothee Chalamet and Brazilian actor Wagner Moura

of "The Secret Agent."

Supporting actor is also a toss-up. Contenders include two

of DiCaprio's "One Battle" costars -- Sean Penn and Benicio del

Toro -- and Stellan Skarsgard for "Sentimental Value."

Teyana Taylor, also from "One Battle After Another," is

competing with Amy Madigan of "Weapons" for supporting actress,

among others.

Winners of the gold Oscar statuettes will be chosen by the

roughly 10,000 actors, producers, directors and ‍film

craftspeople who make up the Academy of Motion Picture Arts and

Sciences.

The ceremony gives Hollywood a night to celebrate at a time

of unease throughout the film business. Warner Bros.,

the studio behind "One Battle" and "Sinners," is in the process

of being sold to Paramount Skydance ( PSKY ) in a deal that will

narrow the ranks of major film distributors. Workers in front of

and behind the camera also are worried that artificial

intelligence will limit job opportunities and stifle creativity

and risk-taking.

Comedian Conan O'Brien will host the Oscars for a second

time after his well-received performance a year ago. The show

will be broadcast live on Walt Disney's ( DIS ) ABC and streamed

on Hulu.

"We have a lot of fun things planned, and we're getting them

up on their feet and seeing how they play at rehearsal. And then

I'm hoping that we have some great choices for Sunday night,"

O'Brien said as he helped roll out the Oscars red carpet on

Hollywood Boulevard on Wednesday.

Performers during the telecast will include the voices of

HUNTR/X, the fictional band in animated film nominee "K-Pop

Demon Hunters."

Producers said the show would reflect the growing presence

of international films at the Oscars. This year, each category

has at least one non-English-language film among the nominees.

Norwegian drama "Sentimental Value" and Brazil's "The Secret

Agent" are in the running for best picture.

"We are celebrating global cinema," executive producer Raj

Kapoor said.

(Reporting by Lisa Richwine; Additional reporting by Hanna

Rantala; Editing by Lincoln Feast.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CPC says it suspended oil loadings from Russia's Novorossiysk due to drone attack
CPC says it suspended oil loadings from Russia's Novorossiysk due to drone attack
Nov 25, 2025
MOSCOW, Nov 25 (Reuters) - The Caspian Pipeline Consortium (CPC) had temporarily suspended oil loadings at its Russian Black Sea's terminal near Novorossiysk due to an overnight drone attack, which damaged its office. It did not provide further comments, referring to its previous statements about its operations, which usually resume once the attack warning is lifted. (Reporting by Vladimir Soldatkin;...
Alibaba beats quarterly revenue estimates
Alibaba beats quarterly revenue estimates
Nov 25, 2025
Nov 25 (Reuters) - Chinese e-commerce giant Alibaba ( BABA ) beat analysts' estimates for quarterly revenue on Tuesday, as investments in one-hour delivery helped drive more users to its shopping apps, while its cloud division reported strong growth. The company reported revenue of 247.80 billion yuan ($34.97 billion) in the second quarter, compared with the estimates of 242.65 billion...
Nio Q3 Adjusted Loss Narrows, Revenue Rises; Q4 Sales Outlook Set; Shares Up Pre-Bell
Nio Q3 Adjusted Loss Narrows, Revenue Rises; Q4 Sales Outlook Set; Shares Up Pre-Bell
Nov 25, 2025
05:34 AM EST, 11/25/2025 (MT Newswires) -- Nio (NIO) reported a Q3 adjusted loss Tuesday of 1.14 Chinese renminbi ($0.16) per diluted American depositary share, narrowing from a loss of 2.14 renminbi a year earlier. Four analysts polled by FactSet expected a loss of 1.66 renminbi. Revenue for the quarter ended Sept. 30 was 21.79 billion renminbi, compared with 18.67...
Novartis Gets FDA Approval for Spinal Muscular Atrophy Treatment; Shares Rise Premarket
Novartis Gets FDA Approval for Spinal Muscular Atrophy Treatment; Shares Rise Premarket
Nov 25, 2025
05:31 AM EST, 11/25/2025 (MT Newswires) -- Novartis ( NVS ) reported Monday that the US Food and Drug Administration has approved itvisma to treat spinal muscular atrophy, or SMA. The gene replacement therapy is for children aged two years and older, teens, and adults, the company said, adding that the treatment addresses the genetic root cause of SMA with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved